1h Free Analyst Time
The assisted reproductive technology (ART) market is forecasted to grow by USD 6.29 billion during 2023-2028, accelerating at a CAGR of 4.36% during the forecast period. The report on the assisted reproductive technology (ART) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in rate of infertility and obesity-related cases, increase in awareness of art, and rise in income level of consumers.
The assisted reproductive technology (ART) market is segmented as below:
By Application
- Fertility clinics
- Hospitals
- Others
By Type
- IVF
- Artificial insemination
By Geographical Landscape
- Europe
- North America
- Asia
- Rest of World (ROW)
The report on the assisted reproductive technology (ART) market covers the following areas:
- Assisted reproductive technology (ART) market sizing
- Assisted reproductive technology (ART) market forecast
- Assisted reproductive technology (ART) market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Application
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global assisted reproductive technology (ART) market: Cook Group Inc., CRITEX GmbH, Cryolab Ltd., Esco Micro Pte. Ltd., Ferring BV, FUJIFILM Holdings Corp., Genea Ltd., Hamilton Thorne Ltd, IMV Technologies, Instituto Bernabeu SL, INVO Bioscience Inc., KITAZATO Corp., Merck KGaA, Monash IVF Group Ltd., Pantec Engineering AG, Smiths Group Plc, The Cooper Companies Inc., Virtus Health, Vitrolife AB, and XiltriX International.Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increasing number of single-parent families."
According to the report, one of the major drivers for this market is the increase in rate of infertility and obesity-related cases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Cook Group Inc.
- CRITEX GmbH
- Cryolab Ltd.
- Esco Micro Pte. Ltd.
- Ferring BV
- FUJIFILM Holdings Corp.
- Genea Ltd.
- Hamilton Thorne Ltd
- IMV Technologies
- Instituto Bernabeu SL
- INVO Bioscience Inc.
- KITAZATO Corp.
- Merck KGaA
- Monash IVF Group Ltd.
- Pantec Engineering AG
- Smiths Group Plc
- The Cooper Companies Inc.
- Virtus Health
- Vitrolife AB
- XiltriX International
